284 results
8-K
EX-99.1
BIO
Bio-Rad Laboratories Inc. - Ordinary Shares
7 May 24
Bio-Rad Reports First-Quarter 2024 Financial Results
4:18pm
. We also adjust for items for which the nature and/or tax jurisdiction requires the application of a specific tax rate or treatment.
From time … by application of a non-GAAP effective tax rate. The non-GAAP tax provision is adjusted for items, the nature of which and/or tax jurisdiction
8-K
EX-10.1
BIO
Bio-Rad Laboratories Inc. - Ordinary Shares
26 Apr 24
Bio-Rad Announces Life Science Group Management Changes
8:30am
that the refusal or failure by the Holder is egregious in nature or is not susceptible of cure, then no such cure period shall be required; or (e) the refusal … , in good faith, determines that the refusal or failure by the Holder is egregious in nature or is not susceptible of cure, then no such cure period shall
8-K
EX-99.1
prxywla1ud
15 Feb 24
Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results
4:24pm
8-K
EX-10.1
ldovqsu0
14 Feb 24
Entry into a Material Definitive Agreement
5:01pm
8-K
ykzxqs 3f4cfnfe
14 Feb 24
Entry into a Material Definitive Agreement
5:01pm
8-K
EX-99.1
2zw uz83d4
26 Oct 23
Bio-Rad Reports Third-Quarter 2023 Financial Results
4:17pm
8-K
EX-99.1
b9yz5if8
3 Aug 23
Bio-Rad Reports Second-Quarter 2023 Financial Results
4:19pm
8-K
EX-99.1
oc3idu7xryi4ccukpo
4 May 23
Bio-Rad Reports First-Quarter 2023 Financial Results
4:18pm
CORRESP
ktzex
14 Dec 22
Correspondence with SEC
12:00am
8-K
EX-99.1
sajzfdqclcplb5nqnc
27 Oct 22
Bio-Rad Reports Third-Quarter 2022 Financial Results
4:12pm